CEOInterviews.AI
Start App
Get an email when Mark Cuban gives a new interview
One email per new interview. Unsubscribe in one click.
Mark Cuban
Co-founder; minority owner, Dallas Mavericks, Cost Plus Drugs

‘Were F—ing Killing It:’ How Mark Cuban Is Disrupting U.S. Healthcare | WSJ

📅 Nov 07, 2025 WSJ News and The Wall Street Journal 11 MIN 25437 VIEWS 63 SEGMENTS · 3 SPEAKERS
Mark Cuban is tackling one of the biggest challenges in the U.S.: the healthcare industry. In a conversation with WSJ's Kate ...I spoke with Cuban about Cost Plus Drugs and the thorniness of the drug business at the "Wall Street Journal"'s Future of Health ...

Questions asked in this interview

10
  1. 0:00If you were president, what would you do?
  2. 0:14So does that mean you would wanna be president?
  3. 2:43But did you go into it seeking to make money or seeking to fix healthcare?
  4. 3:12How many customers do you have?
  5. 3:16You left Shark Tank for this?
  6. 3:44What's the biggest obstacle you have?
  7. 4:56Why is it that you got into this business, which has all of these different players, and you've turned your ire at the PBMs?
  8. 7:56And have you talked with them about this?
  9. 8:26How are you getting the word out?
  10. 9:19Could we see it one more time?
Interviewer 0:00 ↗
If you were president, what would you do?
Mark Cuban 0:02 ↗
The government never would've been closed. We wouldn't have all of this infighting. We'd be a country as opposed to two parties trying to battle it out.
Interviewer 0:14 ↗
So does that mean you would wanna be president?
Mark Cuban 0:17 ↗
No, I have no interest in being president.
Interviewer 0:19 ↗
Zero interest?
Mark Cuban 0:20 ↗
Zero.
Interviewer 0:21 ↗
Never?
Mark Cuban 0:22 ↗
I'm just not a good kissing babies type. You know?
Interviewer 0:26 ↗
Mark Cuban doesn't want to be president, but he does want to overhaul one of the biggest challenges in the US, the healthcare system. And he's trying to do that with his company, Cost Plus Drugs, which is tackling the issue of affordable drug pricing. But in his eyes, that's just the beginning. I spoke with Cuban about Cost Plus Drugs and the thorniness of the drug business at the Wall Street Journal's Future of Health event in DC. So in 2018 you get an email.
Mark Cuban 0:56 ↗
From Dr. Alex Oshmyansky, and he wanted to create, it was a cold email. He wanted to create a compounding pharmacy that made sterile injectable drugs that were on short supply. And he made it clear to me that, you know, these generic drugs like Pitocin and, you know, sterile water and pediatric cancer drugs go on short supply, which made no sense to me. And I thought, that's interesting, but that's not big enough to really have a huge impact. There was other companies that could do that. And it was right around the time the pharma bro, Martin Shkreli, was going to jail. And he had just, you know, he had, in the past, jacked up the price of a generic drug called Daraprim, like 7500%. I'm like, "Alex, how does this happen?" And you start digging in, and the first thing you notice about the pharmacy industry and all of healthcare is that it's incredibly opaque by design. Because when an industry is opaque, then the biggest companies not only get to, you know, charge whatever they want, and nobody knows until it's too late. But you also get regulatory capture, because no one really can tell you what a good price is, bad price is, and obviously-
Interviewer 2:06 ↗
So you were like, this is great business.
Mark Cuban 2:07 ↗
This is a great opportunity.
Interviewer 2:08 ↗
I want in.
Mark Cuban 2:09 ↗
Exactly.
Interviewer 2:10 ↗
Because you wanted more opaque practice or were you-
Mark Cuban 2:14 ↗
No, that's why we are transparent.
Interviewer 2:17 ↗
Oh!
Mark Cuban 2:19 ↗
Because you know, when you look at the healthcare industry, for the most part, people trust their doctors. But when you ask them about the economics of the healthcare industry and do they trust it, people laugh. And does anybody here trust the economic side of the healthcare industry?
Audience Member 2:33 ↗
No.
Mark Cuban 2:34 ↗
Do you like the way things are done? So it was an easy business opportunity, you know? But more importantly, it was an easy fix to help patients.
Interviewer 2:43 ↗
But did you go into it seeking to make money or seeking to fix healthcare?
Mark Cuban 2:48 ↗
Both, you know, and when I say make money, not to maximize my income, but to make enough money that we could reinvest and create new opportunities and help more people.
Interviewer 2:57 ↗
How has it gone?
Mark Cuban 2:59 ↗
We're killing it.
Interviewer 3:01 ↗
Can you define that?
Mark Cuban 3:04 ↗
By word or-
Interviewer 3:06 ↗
In the numbers?
Mark Cuban 3:07 ↗
Oh, the numbers. It's up and to the right. I mean, we've helped millions of people and we continue to grow.
Interviewer 3:12 ↗
How many customers do you have?
Mark Cuban 3:13 ↗
I don't even know, but it's, you know, like I said, we've helped millions of people.

30 more exchanges in this transcript

Sign in free to read the rest of this interview. No card required.

Sign in to read the full transcript

Cite this transcript

APA, MLA, BibTeX
APA

Cuban, M. (2025, November 7). ‘Were F—ing Killing It:’ How Mark Cuban Is Disrupting U.S. Healthcare | WSJ [Interview transcript]. WSJ News and The Wall Street Journal. CEOInterviews.AI. https://ceointerviews.ai/interview/3054516/

MLA

Mark Cuban. "‘Were F—ing Killing It:’ How Mark Cuban Is Disrupting U.S. Healthcare | WSJ." WSJ News and The Wall Street Journal, 7 Nov. 2025. Transcript, CEOInterviews.AI, https://ceointerviews.ai/interview/3054516/.

BibTeX
@misc{cuban2025_3054516,
  author       = {Mark Cuban},
  title        = {‘Were F—ing Killing It:’ How Mark Cuban Is Disrupting U.S. Healthcare | WSJ},
  howpublished = {Interview transcript, WSJ News and The Wall Street Journal. CEOInterviews.AI},
  year         = {2025},
  month        = {nov},
  url          = {https://ceointerviews.ai/interview/3054516/},
  note         = {Speaker-attributed transcript with timestamps}
}